Carla Solórzano

Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK

Merryn Voysey, Sue Ann Costa Clemens, Shabir A. Madhi et al. · The Lancet · 2020 · 5K citations · Full text

Veterinary Medicine, Infectious Diseases, Preventive Medicine +17

Single-dose administration and the influence of the timing of the booster dose on immunogenicity and efficacy of ChAdOx1 nCoV-19 (AZD1222) vaccine: a pooled analysis of four randomised trials

Merryn Voysey, Sue Ann Costa Clemens, Shabir A. Madhi et al. · The Lancet · 2021 · 1.2K citations · Full text

Veterinary Medicine, Immunology, Immunization +16

Safety and immunogenicity of heterologous versus homologous prime-boost schedules with an adenoviral vectored and mRNA COVID-19 vaccine (Com-COV): a single-blind, randomised, non-inferiority trial

Xinxue Liu, R. H. Shaw, Arabella Stuart et al. · The Lancet · 2021 · 545 citations · Full text

Veterinary Medicine, Immunology, Infectious Diseases +17

Inflammation induced by influenza virus impairs human innate immune control of pneumococcus

Simon P. Jochems, Fernando Marcon, Beatriz F. Carniel et al. · Nature Immunology · 2018 · 200 citations · Full text

Life Sciences, Immunology, Microbiology +14

Novel Analysis of Immune Cells from Nasal Microbiopsy Demonstrates Reliable, Reproducible Data for Immune Populations, and Superior Cytokine Detection Compared to Nasal Wash

Simon P. Jochems, Katherine Piddock, Jamie Rylance et al. · PLoS ONE · 2017 · 78 citations · Full text

Life Sciences, Immunology, Microbiology +16